Modifying Enzymes
Echelon Biosciences Research Labs cAMP Dependent Protein Kinase Inhibitor 5-24 amide - 1 mg, CAS#: 100853-58-5
cAMP Dependent Protein Kinase Inhibitor 5-24 amide - 1mg , Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-His-Asp-NH2 This item is non returnable
Alkali Scientific Radiant™ HiFi Pro™ Hot Start Enzyme, 2u/ul with 5X Buffer, 100 Reactions, with Enhancer Juice
Radiant™ HiFi Pro™ Hot Start Enzyme, 2u/ul with 5X Buffer, 100 Reactions, with Enhancer Juice, provides excellent amplification capabilities for high-fidelity PCR. This enzyme system is designed for precise and reliable DNA amplification with minimal errors. The 5X buffer ensures optimal reaction conditions, while the enhancer juice improves amplification efficiency, making it perfect for difficult templates. It is ideal for researchers who require high-quality results in a variety of PCR applications.
Carnabio Usa Inc RSK4(RPS6KA6)/5UG/FULL-LENGTH
RSK4(RPS6KA6), Full-length, Wild type, Amino Acid 1-745, NP_055311.1, Expressed in Insect (sf21); 5microg
Carnabio Usa Inc MST2(STK3)/5UG/FULL-LENGTH
MST2(STK3), Full-length, Wild type, Amino Acid 1-491, Q13188, Expressed in Insect (sf21); 5microg
Meridian Life Science Lyo-Ready T4 Ligase Buffer, 1ML
Lyo-Ready T4 Ligase Buffer, 5x is a glycerol-free ligation reaction buffer containing ATP and lyo-excipients. It is designed to be used with Glycerol-Free T4 DNA Ligase (HC) (MDX200) to create a wet mix or a lyophilized, ambient-temperature stable mix for the ligation of cohesive blunt ended DNA.
Amsbio LLC Positive Control Enzyme (Hyaluronidase Assay Kit)
Positive Control Enzyme (Hyaluronidase Assay Kit)
Cayman Chemical Oleoyl-D-lysInsodIum salt 25mg
An inhibitor of GlyT2a; selectively inhibits GlyT2a (IC50 = 48.3 nM) over GlyT1b (IC50 = >3,000 nM) in Xenopus oocytes expressing the human transporters; reduces allodynia in a nerve ligation rat model of neuropathic pain at 30 mg/kg, i.p.
Cayman Chemical Oleoyl SerotonIn-d17 5mg
An internal standard for the quantification of oleoyl serotonin by GC- or LC-MS
Bioworld Beta-Glactosidase, 1000 Unit(s)
Beta-Galactosidase Enzyme found in lac+ bacterial cells that catalyzes the cleavage of -linked terminal galactose-containing substratesLyophilized powderSource: E. coliConjugation gradeActivity (37°C):800-1000U/mg proteinUnit definition: One unit will hydrolyze 1.0 μmole of o-nitrophenyl β-D-galactoside to o-nitrophenol and D-galactose per min at pH7.3 at 37°C, 410nm.Aggregation (HPLC): <3.0%Application: Used as an indicator enzyme conjugated to proteins such as antibodies.
Cayman Chemical Lysosomal ACD LIpase ActIvIt
Cayman's LAL Activity MaxSpec Assay Kit includes the necessary reagents to quantify lysosomal acid lipase (LAL) activity in dried blood spots. The LAL Activity MaxSpec Assay Substrate (P-PMHC) has been designed to function as a highly selective substrate for LAL, which hydrolyzes the fatty acyl group of P-PMHC resulting in the formation of the LAL Activity MaxSpec Assay Product 4-propyl-8-methyl-7-hydroxycoumarin (PMHC). Using the LAL Activity MaxSpec Assay Kit, LAL activity may be quantified directly by fluorometry or by LC-MS in combination with the LAL Activity MaxSpec Assay Internal Standard.
Abcam beta-Lapachone, Topoisomerase I inhibitor, 10MG
MW 244.28 Da, Purity >98%. Topoisomerase I inhibitor. Inhibits topoisomerase I induced DNA cleavage. Induces apoptosis via a p53 independent mechanism. Shows antitumor, antiviral, antibacterial, antifungal and wound healing activities.
The product is subject to the following: Abcam Restricted Use Statement
QA Bio Inc QA-Bio, Inc. • Neuraminidase Au • recombinant from A. ureafaciens • 60 µls
Neuraminidase Au - 60 µls • Alpha (2-3,6,8,9) Neuraminidase (Sialidase) cleaves all non-reducing terminal neuraminic acid residues from complex carbohydrates and glycoproteins.
Cayman Chemical Coenzyme AlIthIM salt hydr
An essential cofactor functioning as an acyl group carrier and carbonyl-activating group for the citric acid cycle and fatty acid metabolism; the pantothenate kinase step of the CoA biosynthetic pathway has been identified as a target for the development of antibacterial compounds